Search Results - "Islam, Mahnoor"

Differences in symptoms and presentation delay times in myocardial infarction patients with and without diabetes: A cross-sectional study in Pakistan by Ahmed, Saba, Khan, Ariba, Ali, Syed Ibaad, Saad, Mohammad, Jawaid, Hafsa, Islam, Mahnoor, Saiyed, Hanieya, Fatima, Sarosh, Khan, Aiman, Basham, Maleeha A., Hussain, Syeda Asfia, Akhtar, Maheen, Kausar, Fatima, Hussain, Afshan, Fatima, Kaneez

“…A short pre-hospital delay, from the onset of symptoms to rapid initiation of reperfusion therapy, is a crucial factor in determining prognosis of myocardial…”
Get full text

Extensively Drug-Resistant Tuberculosis in the Time of COVID-19-How has the Landscape Changed for Pakistan? by Islam, Mahnoor

“…The incidence of extensively drug-resistant tuberculosis (XDR-TB) has been rising consistently in Pakistan, and the country is likely to experience another…”
Get more information

Neurological manifestations in dengue infection: The need to be vigilant by Islam, Mahnoor

Get full text

Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings

Get full text

NIMG-61. TRANSVENTRICULAR MIGRATION OF CESIUM-131 BRACHYTHERAPY SEEDS TO THE SACRAL THECAL SAC IN A PATIENT TREATED FOR RECURRENT GLIOBLASTOMA by Islam, Mahnoor, Varma, Abhay, Rivers, Charlotte, Godwin, William, Takacs, Istvan, Zukas, Alicia

“…Abstract Cesium-131 brachytherapy (GammaTileTM) is a relatively new form of surgically targeted radiation therapy for recurrent glioblastoma. While seed…”
Get full text

Source of funding and enrollment disparity in prostate cancer (PCa) clinical trials by Riaz, Irbaz Bin, Naqvi, Syed Arsalan Ahmed, Islam, Mahnoor, Ikram, Waleed, Khakwani, Kaneez Zahra Rubab, Ijaz, Hafsah, Ayaz, Ahsan, Singh, Parminder, Bryce, Alan Haruo

“…40 Background: Previously we have reported enrollment disparities in PCa clinical trials. Funding source can influence minority representation in clinical…”
Get full text

Source of funding and enrollment disparities in the inclusion of minorities in colorectal clinical trials: A systematic review and meta-analysis by Ayaz, Ahsan, Naqvi, Syed Arsalan Ahmed, Islam, Mahnoor, Ikram, Waleed, Raza, Umar, Riaz, Anum, Khakwani, Kaneez Zahra Rubab, Ijaz, Hafsah, Sonbol, Bassam Bassam, Jin, Zhaohui, Riaz, Irbaz Bin

“…23 Background: Identification of factors associated with enrollment disparities in clinical trials can narrow cancer care inequities. Funding source can…”
Get full text

Indirect comparisons of triplet therapy as compared to novel hormonal therapy doublets in patients with metastatic castration sensitive prostate cancer by Naqvi, Syed Arsalan Ahmed, Riaz, Zaryab Bin, Riaz, Anum, Islam, Mahnoor, Siddiqi, Rabbia, Ikram, Waleed, Bin Zafar, Muhammad Daim, Singh, Parminder, Riaz, Irbaz Bin, Bryce, Alan Haruo

“…5083 Background: ARASENS and PEACE-1 trials suggests treatment intensification with novel hormonal therapy (NHT) in addition to androgen deprivation therapy…”
Get full text

Differential efficacy of PARP inhibitors in metastatic castration-resistant prostate cancer with DNA repair defects: A systematic review and meta-analysis by Naqvi, Syed Arsalan Ahmed, Bin Zafar, Muhammad Daim, Islam, Mahnoor, Ikram, Waleed, Raina, Ammad, Singh, Parminder, Riaz, Irbaz Bin, Bryce, Alan Haruo

“…Abstract only 134 Background: Recent trials have suggested poly ADP-ribose polymerase inhibitors (PARPi) sensitivity in patients with treatment-refractory…”
Get full text

Source of funding and enrollment disparity in cancer clinical trials by Riaz, Irbaz Bin, Ijaz, Hafsah, Naqvi, Syed Arsalan Ahmed, Islam, Mahnoor, Kumar, Gaurav, Mumtaz, Aqsa, Khakwani, Kaneez Zahra Rubab, Ayaz, Ahsan, Tripathi, Nikita, Singh, Parminder, Kamran, Sophia C., Warner, Jeremy Lyle, Bryce, Alan Haruo

“…6559 Background: Recent findings that Black and Hispanic patients were significantly underrepresented in industry-sponsored prostate cancer trials warrant a…”
Get full text

A quantitative synthesis of disparities in the inclusion of racial/ethnic minorities and older women in breast cancer trials by Islam, Mahnoor, Naqvi, Syed Arsalan Ahmed, Bin Zafar, Muhammad Daim, Ayaz, Ahsan, Saleem, Yusra, Khalid, Atiqa, Wazir, Muhammad Hisham Khan, Ijaz, Hafsah, Giridhar, Karthik, Yadav, Siddhartha, Ernst, Brenda, Riaz, Irbaz Bin

“…6557 Background: Trials that inadequately include underrepresented minority (URM) populations widen inequities in cancer care. We assessed reporting patterns,…”
Get full text

Socioeconomic vulnerability and the risk of genitourinary cancer mortality among United States counties by Riaz, Anum, Saleem, Yusra, Naqvi, Syed Arsalan Ahmed, Islam, Mahnoor, Kazmi, Syeda Zainab, Khakwani, Kaneez Zahra Rubab, Khan, Safi U., Singh, Parminder, Hammode, Emad, Riaz, Irbaz Bin, Bryce, Alan Haruo

“…116 Background: The impact of socioeconomic status on genitourinary (GU) cancer mortality in the United States (US) is unclear. Hence, we evaluated the…”
Get full text

Adjuvant immunotherapy in renal cell carcinoma: A living systematic review and network meta-analysis (NMA) by Sipra, Qurat Ul Ain Riaz, Riaz, Irbaz Bin, Naqvi, Syed Arsalan Ahmed, He, Huan, Siddiqi, Rabbia, Islam, Mahnoor, Asghar, Noureen, Ikram, Waleed, Xu, Wenxin (Vincent), Singh, Parminder, Ho, Thai Huu, Bilen, Mehmet Asim, Zakharia, Yousef, Bryce, Alan Haruo

“…694 Background: The treatment landscape of localized renal cell carcinoma (RCC) is rapidly evolving. Recent trials have demonstrated contrasting efficacy with…”
Get full text

Social vulnerability and gastrointestinal cancer mortality among United States counties by Naqvi, Syed Arsalan Ahmed, Saleem, Yusra, Faisal, Kunwer Sufyan, Islam, Mahnoor, Ayaz, Ahsan, Ijaz, Hafsah, Khan, Komal, Kazmi, Syeda Zainab, Bin Zafar, Muhammad Daim, Sonbol, Bassam Bassam, Jin, Zhaohui, Khan, Safi U., Riaz, Irbaz Bin

“…499 Background: The impact of socioeconomic status on gastrointestinal (GI) cancer mortality in the United States (US) is not well-established. We hypothesized…”
Get full text

Quantifying the absolute benefit of neoadjuvant chemotherapy followed by definitive therapy in patients with muscle-invasive bladder cancer: A systematic review and meta-analysis by Ikram, Waleed, Naqvi, Syed Arsalan Ahmed, Raina, Ammad, Fatima, Ezza, Siddiqi, Rabbia, Islam, Mahnoor, Asghar, Noureen, Khakwani, Kaneez Zahra Rubab, Khan, Ahsan Masood, Hussain, Syed A., Bryce, Alan Haruo, Riaz, Irbaz Bin, Singh, Parminder

“…4594 Background: Cisplatin based neoadjuvant chemotherapy (NAC) followed by definitive therapy improves survival in patients with muscle invasive bladder…”
Get full text

Antiangiogenic exclusion rules in glioma trials: Historical perspectives and guidance for future trial design by Sener, Ugur, Islam, Mahnoor, Webb, Mason, Kizilbash, Sani H

“…Abstract Background Despite the lack of proven therapies for recurrent high-grade glioma (HGG), only 8%–11% of patients with glioblastoma participate in…”
Get full text

Quantifying absolute benefit of adjuvant treatments in renal cell carcinoma: A systematic review and network-meta-analysis by Sipra, Qurat Ul Ain Riaz, Naqvi, Syed Arsalan Ahmed, Islam, Mahnoor, Asghar, Noureen, Siddiqi, Rabbia, Ikram, Waleed, Singh, Parminder, Xu, Wenxin, Ho, Thai Huu, Bryce, Alan Haruo, Riaz, Irbaz Bin

“…Abstract only 360 Background: Pembrolizumab has been established as an effective treatment option in adjuvant renal cell carcinoma after the publication of…”
Get full text

A quantitative synthesis of disparities in the inclusion of racial/ethnic minorities and older adults in prostate cancer clinical trials over the last three decades by Riaz, Irbaz Bin, Islam, Mahnoor, Ikram, Waleed, Naqvi, Syed Arsalan Ahmed, Maqsood, Hamza, Saleem, Yusra, Riaz, Anum, Ravi, Praful, Hussain, Syed A., Warner, Jeremy Lyle, Odedina, Folakemi, Duma, Narjust, Singh, Parminder, Bryce, Alan Haruo

“…Abstract only 26 Background: The underrepresentation of minority populations in clinical trials negatively impacts cancer and widens inequities. We aimed to…”
Get full text

A systematic review and network meta-analysis evaluating neoadjuvant treatments in muscle-invasive bladder cancer by Ikram, Waleed, Naqvi, Syed Arsalan Ahmed, Fatima, Ezza, Siddiqi, Rabbia, Islam, Mahnoor, Asghar, Noureen, Khakwani, Kaneez Zahra Rubab, Khan, Ahsan Masood, Xu, Wenxin, Hussain, Syed A., Sonpavde, Guru P., Bryce, Alan Haruo, Riaz, Irbaz Bin, Singh, Parminder

“…Abstract only 518 Background: Cisplatin (C) based neoadjuvant chemotherapy (NAC) has been the mainstay treatment for muscle invasive bladder cancer (MIBC)…”
Get full text

Triplet therapy in metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis by Naqvi, Syed Arsalan Ahmed, Riaz, Zaryab Bin, Riaz, Anum, Islam, Mahnoor, Siddiqi, Rabbia, Ikram, Waleed, Jafar, Muhammad Ali, Singh, Parminder, Ravi, Praful Kumar, Riaz, Irbaz Bin, Bryce, Alan Haruo

“…Abstract only 136 Background: Intensification of initial treatment of in patients with metastatic castration-sensitive prostate cancer (mCSPC) with androgen…”
Get full text